AusDiagnostics
AusDiagnostics is an Australian manufacturer and supplier of highly multiplexed molecular diagnostics products and reagents, founded in 2006 in Mascot, serving clinical and applied testing customers through proprietary assay chemistry and instrumentation.
- Company typePrivate
- Founded2006
- HeadquartersMascot, Australia
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What AusDiagnostics does
AusDiagnostics is a private Australian manufacturer and supplier of highly multiplexed molecular diagnostics products and reagents, founded in 2006 and headquartered in Mascot, New South Wales. The company operates in the in-vitro diagnostics subsegment of the broader medical devices industry, with employee scale in the 101–250 range and a managing director (Keith Stanley) who appears to provide long-tenured leadership continuity. AusDiagnostics' stated positioning emphasizes "highly multiplexed" molecular chemistry — a technically specialized subsegment of IVD that allows many pathogens or targets to be interrogated simultaneously from a single sample, distinguishing it from singleplex assay providers.
The aggregated source material indicates an apparent partnership or distribution relationship with R-Biopharm Australia, whose catalog (r-biopharm.com.au) lists products spanning human clinical diagnostics (respiratory pathogens, gastrointestinal, sexual health, urinary tract infections, dermatophytes, drug resistance, hospital care, vector-borne infections, women's health), animal health diagnostics, applied testing, and food/feed analysis (constituents, allergens, GMOs, microbiology, mycotoxins, residues, vitamins). The technology portfolio associated with this distribution arrangement includes instruments (RIDA®Xplore, RIDA®CYCLER, RIDA®CUBE SCAN, RIDA®ABSORBANCE 96, ThunderBolt®, Pictus 500), sample-preparation kits (RIDA®Prep and RIDA®Xtract series), automated systems (CHRONECT Symbiosis RIDA®CREST), and mobile applications (RIDA®SMART APP Allergen/Mycotoxin), suggesting B2B sales into clinical pathology laboratories, food and feed testing facilities, and applied-testing customers.
Public pricing, revenue, customer-logo, and competitive-displacement data were not available in the input, so the company's revenue mechanics, contract structure, and pricing model cannot be characterized with confidence. What is clear is the business model archetype — a consumables-led molecular diagnostics manufacturer with proprietary reagents and supporting instrumentation, distributed at least in part through Australian specialty diagnostics channels.
AusDiagnostics firmographics
Firmographics- Name
- AusDiagnostics
- Website
- https://ausdiagnostics.com
- Company type
- Private
- Founded year
- 2006
- Operating status
- Unknown
- Headcount range
- 101–250 employees
- Short description
- AusDiagnostics is an Australian manufacturer and supplier of highly multiplexed molecular diagnostics products and reagents, founded in 2006 in Mascot, serving clinical and applied testing customers through proprietary assay chemistry and instrumentation.
- Ownership category
- akta.pro rank
AusDiagnostics industry classification
Industry- Product category
- Molecular Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL)
Keywords
Where AusDiagnostics is headquartered
LocationHeadquarters
- HQ city
- Mascot
- HQ country
- Australia
- HQ region
- Oceania
Markets served
AusDiagnostics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
AusDiagnostics product offering
Product offeringCore offering
AusDiagnostics manufactures and supplies highly multiplexed molecular diagnostics products and reagents, including real-time PCR instruments, automated sample preparation systems, and assay kits for pathogen, allergen, and mycotoxin detection. The portfolio is used by clinical diagnostics laboratories, food and feed testing facilities, animal health laboratories, and research institutions running high-throughput in-vitro diagnostic workflows. Complementary services include technical support, validation guidance, and instrument service delivered to laboratory customers.
Product overview
R-Biopharm provides high-quality testing solutions spanning clinical diagnostics and food & feed analysis. The portfolio includes instruments (RIDA®Xplore, RIDA®CYCLER, RIDA®CUBE SCAN, RIDA®ABSORBANCE 96, ThunderBolt®, Picto 500), sample preparation kits (RIDA®Prep series, RIDA®Xtract series), technology platforms (RIDA®Xplore Alliance, RIDA®Jump Alliance), mobile applications (RIDA®SMART APP Allergen, RIDA®SMART APP Mycotoxin), and automated systems (CHRONECT Symbiosis RIDA®CREST). The diagnostics division covers human health areas (dermatophytes, gastrointestinal, respiratory pathogens, hospital care, drug resistance, sexual health, urinary tract infections, women's health, vector-borne infections) and animal health. The food & feed analysis division addresses constituents, food adulteration, allergens, GMOs, microbiology, mycotoxins, and residues.
Differentiator
Problem solved
Functional benefit
Products and services
- RIDA®Xplore Automated molecular diagnostics instrument used by laboratories to run multiplexed PCR assays for pathogen, allergen, and analyte detection.
- RIDA®CYCLER Real-time PCR thermal cycler for running multiplexed molecular diagnostic assays in clinical and applied testing laboratories.
- RIDA®CUBE SCAN Absorbance scanner used in lateral-flow and ELISA-based diagnostic workflows alongside R-Biopharm/AusDiagnostics test kits.
- RIDA®ABSORBANCE 96 96-well plate absorbance reader for quantitative ELISA and end-point immunoassay workflows in diagnostic laboratories.
- ThunderBolt® Molecular diagnostics instrument used to perform multiplexed real-time PCR detection in research and applied testing settings.
- Pictus 500 Real-time PCR instrument supporting molecular diagnostic assay runs in clinical and research laboratories.
- CHRONECT Symbiosis RIDA®CREST Automated sample-handling and LC-MS interface system that couples sample preparation to chromatographic detection for food and feed safety testing.
- RIDA®SMART BOX Smart instrument for rapid allergen and mycotoxin lateral-flow test evaluation in food and feed testing laboratories.
- RIDA®Xtract 24 Automated 24-sample nucleic acid extraction system used to prepare clinical, food, and animal samples for downstream PCR testing.
- RIDA®Xtract 96 High-throughput 96-sample nucleic acid extraction platform for laboratories running high-volume molecular diagnostic workflows.
- RIDA®Xtract 24 Pathogen Kit Reagent kit for automated pathogen nucleic acid extraction on the RIDA®Xtract 24 system, used prior to multiplexed PCR detection.
- RIDA®Xtract 24 Blood DNA Kit Reagent kit for automated DNA extraction from blood samples on the RIDA®Xtract 24 platform for downstream diagnostic testing.
- RIDA®Xtract 96 DNA/RNA Kit Reagent kit for high-throughput DNA and RNA extraction on the RIDA®Xtract 96 system, supporting multiplexed PCR workflows.
- RIDA®Prep Tissue Digestion Kit Sample preparation kit for tissue digestion prior to nucleic acid extraction in molecular diagnostic workflows.
- RIDA®PrepX Stool Kit Stool sample preparation kit used to extract nucleic acids from fecal samples for downstream gastrointestinal pathogen PCR testing.
- RIDA®UNITY Software/data management offering for diagnostic laboratories to manage, interpret, and report molecular test results.
- BioQuant Quantitative data analysis tool used in molecular diagnostic workflows to evaluate PCR and assay results.
- RIDA®Xplore Alliance Integrated molecular diagnostics platform based on the RIDA®Xplore instrument, supporting multiplexed assay workflows for laboratories.
- RIDA®Jump Alliance Integrated molecular diagnostics platform providing standardized, scalable multiplexed PCR workflows for diagnostic laboratories.
Companies that use AusDiagnostics
Customer profileIdeal customer profiles1 record
AusDiagnostics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AusDiagnostics partnerships and signals
Strategic signalRecent moves3 records
Expansion highlights3 records
AusDiagnostics competitors and assessment
Company assessmentDirect peers
- ELITech Group: Mid-sized specialty IVD manufacturer focused on molecular diagnostics (ELITe InGenius, MGB assays) and clinical chemistry — closely comparable specialty multiplex IVD company.
- Seegene: Korea-based specialist in multiplex molecular diagnostics (Allplex assays) covering respiratory, GI, STI, and drug-resistance panels — direct head-to-head competitor in syndromic multiplex real-time PCR testing.
- R-Biopharm AG: German parent group that owns the R-Biopharm product portfolio (RIDA® kits and instruments) appearing in the source data; operates the exact same clinical-IVD and food/feed-testing kit lines, and is therefore the closest direct comp to AusDiagnostics' distribution and manufacturing scope.
Broad incumbents
- QIAGEN: Large global molecular diagnostics / sample-prep leader (QIAamp, QIAstat-Dx, QuantiFeron) with multiplex assay panels and consumables across human and applied testing — broadly comparable to AusDiagnostics' integrated IVD manufacturing footprint but at significantly greater scale.
- Bio-Rad Laboratories: Established life-science research and clinical diagnostics manufacturer offering multiplex digital-PCR (ddPCR) platforms and sample-prep kits; competes with AusDiagnostics in the broader molecular diagnostics and lab consumables market.
- bioMérieux: Global in vitro diagnostics leader with BioFire FilmArray syndromic panels and industrial microbiology solutions spanning human, animal, and food testing — competes on the molecular diagnostics side of AusDiagnostics' portfolio.
- Hologic: Diagnostics franchise (Panther, Aptima, Panther Fusion) dominating women's health and molecular STI testing — directly overlaps with AusDiagnostics' sexual health and women's health assay categories.
- DiaSorin (formerly Luminex): Now owns the Luminex multiplex bead-based assay franchise (xMAP) which competes with high-throughput multiplex molecular and immunoassay platforms at the core of AusDiagnostics' technology stack.
- Cepheid (Danaher): Owner of the GeneXpert rapid molecular testing platform with syndromic panels (Xpress, Respiratory, CT/NG) — global incumbent in clinical molecular diagnostics competing head-to-head in hospital lab channels.
Regional players
- Genetic Signatures: Australian-headquartered molecular diagnostics specialist in syndromic enteric and respiratory panels (EasyScreen) — the closest home-market peer for AusDiagnostics operating in the same Australian laboratory channel.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights4 records
Customer concentration
AusDiagnostics social profiles
Digital presenceAusDiagnostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
AusDiagnostics leadership team
Management profileNumber of profiles
Profiles1 record
AusDiagnostics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AusDiagnostics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AusDiagnostics
What does AusDiagnostics do?
AusDiagnostics manufactures and supplies highly multiplexed molecular diagnostics products and reagents, including real-time PCR instruments, automated sample preparation systems, and assay kits for pathogen, allergen, and mycotoxin detection. The portfolio is used by clinical diagnostics laboratories, food and feed testing facilities, animal health laboratories, and research institutions running high-throughput in-vitro diagnostic workflows. Complementary services include technical support, validation guidance, and instrument service delivered to laboratory customers.
Is AusDiagnostics a public or private company?
AusDiagnostics is a private company. It is classified as unknown and is currently unknown.
When was AusDiagnostics founded?
AusDiagnostics was founded in 2006. It employs 101 to 250 people.
Where is AusDiagnostics based?
AusDiagnostics is headquartered in Mascot, Australia, in the Oceania region.
Who are AusDiagnostics's main competitors?
Direct peers on record are ELITech Group, Seegene and R-Biopharm AG. Broad incumbents are QIAGEN, Bio-Rad Laboratories, bioMérieux, Hologic, DiaSorin (formerly Luminex) and Cepheid (Danaher). Genetic Signatures is listed as a regional player.
Does AusDiagnostics have an API?
No public API is recorded for AusDiagnostics.
What industry is AusDiagnostics in?
AusDiagnostics's product category is Molecular Diagnostics. Its primary akta.pro industry code is HLAAALAL, Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays). Its NAICS code is 325413 and its SIC code is 2835.